Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis
Abnormal expression of Forkhead box protein M1 (FOXM1) and serine/threonine kinase Budding uninhibited by benzimidazoles 1 (BUB1B) contributes to the development and progression of several cancers, including chronic myelogenous leukemia (CML). However, the molecular mechanism of the FOXM1/BUB1B regu...
Main Authors: | Shilpa Kuttikrishnan, Tariq Masoodi, Gulab Sher, Ajaz A. Bhat, Kalyani Patil, Tamam El-Elimat, Nicholas H. Oberlies, Cedric J. Pearce, Mohmmad Haris, Aamir Ahmad, Feras Q. Alali, Shahab Uddin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.929996/full |
Similar Items
-
Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancer
by: Abbas Khan, et al.
Published: (2024-02-01) -
Clinical value and potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinoma
by: Li-Ting Qin, et al.
Published: (2022-12-01) -
FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c
by: Andy King Yin Lam, et al.
Published: (2013-01-01) -
Identification of the hub gene BUB1B in hepatocellular carcinoma via bioinformatic analysis and in vitro experiments
by: Jie Fu, et al.
Published: (2021-02-01) -
m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation
by: Yuan Gao, et al.
Published: (2024-03-01)